- Home
- AMS vs CLDI Comparison
AMS vs CLDI Comparison
Compare AMS & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- CLDI
- Stock Information
- Founded
- AMS 1980
- CLDI 2014
- Country
- AMS United States
- CLDI United States
- Employees
- AMS N/A
- CLDI N/A
- Industry
- AMS Medical Specialities
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMS Health Care
- CLDI Health Care
- Exchange
- AMS Nasdaq
- CLDI Nasdaq
- Market Cap
- AMS 17.9M
- CLDI 15.7M
- IPO Year
- AMS N/A
- CLDI N/A
- Fundamental
- Price
- AMS $2.98
- CLDI $0.40
- Analyst Decision
- AMS
- CLDI Strong Buy
- Analyst Count
- AMS 0
- CLDI 2
- Target Price
- AMS N/A
- CLDI $15.00
- AVG Volume (30 Days)
- AMS 7.0K
- CLDI 202.0K
- Earning Date
- AMS 05-15-2025
- CLDI 05-20-2025
- Dividend Yield
- AMS N/A
- CLDI N/A
- EPS Growth
- AMS 243.96
- CLDI N/A
- EPS
- AMS 0.33
- CLDI N/A
- Revenue
- AMS $28,340,000.00
- CLDI N/A
- Revenue This Year
- AMS $23.63
- CLDI N/A
- Revenue Next Year
- AMS N/A
- CLDI N/A
- P/E Ratio
- AMS $8.76
- CLDI N/A
- Revenue Growth
- AMS 32.90
- CLDI N/A
- 52 Week Low
- AMS $2.51
- CLDI $0.35
- 52 Week High
- AMS $4.60
- CLDI $4.90
- Technical
- Relative Strength Index (RSI)
- AMS 61.91
- CLDI 34.35
- Support Level
- AMS $2.68
- CLDI $0.41
- Resistance Level
- AMS $2.80
- CLDI $0.46
- Average True Range (ATR)
- AMS 0.08
- CLDI 0.04
- MACD
- AMS 0.02
- CLDI 0.01
- Stochastic Oscillator
- AMS 94.12
- CLDI 0.00
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.